ST Pharm Co.,Ltd. (KOSDAQ:237690)
73,900
+300 (0.41%)
May 14, 2025, 2:40 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Raw Pharmaceutical Products | 251.56B |
Log In |
Log In |
Log In |
Log In |
Raw Pharmaceutical Products Growth | 20.21% |
Log In |
Log In |
Log In |
Log In |
Clinical Trial Contract Research | 33.43B |
Log In |
Log In |
Log In |
Log In |
Clinical Trial Contract Research Growth | -16.52% |
Log In |
Log In |
Log In |
Log In |
New Drugs and Generic Drug Product | - |
Log In |
Log In |
Log In |
Log In |
New Drugs and Generic Drug Product Growth | - |
Log In |
Log In |
Log In |
Log In |
New Drugs and Generic Drug Merchandise | - |
Log In |
Log In |
Log In |
Log In |
New Drugs and Generic Drug Merchandise Growth | - |
Log In |
Log In |
Log In |
Log In |
Service | - |
Log In |
Log In |
Log In |
Log In |
Service Growth | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Switzerland | 98.64B |
Log In |
Log In |
Log In |
Log In |
Switzerland Growth | -10.53% |
Log In |
Log In |
Log In |
Log In |
Other Countries | 66.28B |
Log In |
Log In |
Log In |
Log In |
Other Countries Growth | 17.94% |
Log In |
Log In |
Log In |
Log In |
South Korea | 51.95B |
Log In |
Log In |
Log In |
Log In |
South Korea Growth | -1.17% |
Log In |
Log In |
Log In |
Log In |
United States | 39.84B |
Log In |
Log In |
Log In |
Log In |
United States Growth | 31.45% |
Log In |
Log In |
Log In |
Log In |
Belgium | 28.28B |
Log In |
Log In |
Log In |
Log In |
Spain | - |
Log In |
Log In |
Log In |
Log In |